Cargando…

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma

Semaphorin 4C (SEMA4C), is an important regulator of axonal guidance and aggravates tumor development. However, the roles and prognostic value of SEMA4C in colorectal cancer (CRC) remain unclear. Here, bioinformatics analyses of transcriptome data from multiple CRC patient datasets and immunohistoch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Yufang, Wang, Weiqi, Zeng, Zifan, Gan, Wenqiang, Lv, Silin, Li, Tiegang, Yan, Zheng, Zhang, Rixin, Yang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695389/ https://www.ncbi.nlm.nih.gov/pubmed/33177246 http://dx.doi.org/10.18632/aging.104038

Ejemplares similares

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis
por: Zhang, Rixin, et al.
Publicado: (2020)

Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer
por: Hou, Yufang, et al.
Publicado: (2022)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
por: Zhou, Mingxuan, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy
por: Li, Tiegang, et al.
Publicado: (2022)

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma
por: Gan, Wenqiang, et al.
Publicado: (2022)

Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023)

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
por: Zhang, Fang, et al.
Publicado: (2023)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019
por: Wang, Weiqi, et al.
Publicado: (2020)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
por: Woischke, Christine, et al.
Publicado: (2016)

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
por: Zhou, Rui, et al.
Publicado: (2017)

Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer
por: Tseng, Chun-Hsien, et al.
Publicado: (2011)

Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma
por: Liu, Jianhua, et al.
Publicado: (2018)

SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
por: Liu, Ruoyan, et al.
Publicado: (2019)

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer
por: Kurashige, Junji, et al.
Publicado: (2019)

Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelial–mesenchymal transition in renal tubular epithelial cells
por: Zeng, Rui, et al.
Publicado: (2011)

Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021)

HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling
por: Li, Qinghua, et al.
Publicado: (2017)

Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients
por: Zhang, Zizhen, et al.
Publicado: (2020)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer
por: Hu, Cheng-En, et al.
Publicado: (2017)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis
por: Jiang, Shuai, et al.
Publicado: (2021)

Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma
por: Lv, Qiao-Li, et al.
Publicado: (2016)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
por: Xia, You-You, et al.
Publicado: (2015)

MACC1 Is Associated With Epithelial–Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma
por: Cheng, Hao, et al.
Publicado: (2021)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
por: Yang, Qingling, et al.
Publicado: (2014)

MiR-146b-5p/SEMA3G regulates epithelial-mesenchymal transition in clear cell renal cell carcinoma
por: Tang, Mengxi, et al.
Publicado: (2023)

The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition
por: Sun, Junfeng, et al.
Publicado: (2016)

Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer
por: Liu, Chen-Chi, et al.
Publicado: (2016)

High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer
por: Yu, Wei, et al.
Publicado: (2018)

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
por: Pang, Zhaofei, et al.
Publicado: (2019)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
por: Tian, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_scbkg6l27kosm7jrrodd2c1ga9